title: Clinical Evaluation of a Skin Protectant for the Management of Incontinence-Associated Dermatitis: An Open-Label, Nonrandomized, Prospective Study.
abstract: OBJECTIVE
  The purpose of this study was to evaluate the efficacy of an investigational skin protectant product at managing severe skin breakdown associated with incontinence.
  
  
  METHODS
  Open-label, nonrandomized, prospective study.
  
  
  METHODS
  The sample comprised 16 patients; inclusion criteria were: patients older than 18 years, cared for in the intensive care unit of a level I trauma center hospital or in long-term care facilities in the northeast region of the United States, and had incontinence-associated dermatitis (IAD). Twelve of the patients had epidermal skin loss and 4 had severe redness.
  
  
  METHODS
  The investigational product is a formulation based on acrylate chemistry. The skin protectant application schedule was twice weekly for up to 3 weeks for a maximum of 6 applications during the study period. The skin was evaluated via a skin assessment instrument specifically designed for use in this study; this instrument has not undergone validation studies. The main outcome measure was changes in the instrument score over time. In addition, complete reepithelialization was recorded when observed, and pain scores (associated with IAD) were noted in participants who were able to report pain.
  
  
  RESULTS
  The IAD score improved in 13 of 16 patients, remained unchanged in 1 patient, and deteriorated in 2 patients. The median percent improvement in the skin assessment instrument was 96% (P = .013). Four of the patients with epidermal skin loss had complete reepithelialization of the skin surface with 4 to 6 applications of the skin protectant, and 5 had substantial improvement. The 4 patients with severe red skin returned to healthy normal skin with 2 to 4 skin protectant applications. Substantial pain reduction was reported by all 9 patients who reported pain at enrollment. No adverse events associated with the skin protectant application were reported during data collection.
  
  
  CONCLUSIONS
  Results of this study suggest that an acrylate-based product, evaluated here for the first time in patients, may be effective as a protective barrier in the presence of continued incontinence. Additional research is needed to confirm these findings.
authors.affiliation: Mary R. Brennan, MBA, RN, CWON, North Shore University Hospital, Manhasset, New York. Catherine T. Milne, MSN, APRN, BC-ANP, CWOCN-AP, Connecticut Clinical Nursing Associates, Bristol, Connecticut. Marie Agrell-Kann, MSN, RN, CDE, CWCN, North Shore University Hospital, Manhasset, New York. Bruce P. Ekholm, MS, 3M, St Paul, Minnesota.
authors.forename: Mary R
authors.initials: MR
authors.lastname: Brennan
authors.forename: Catherine T
authors.initials: CT
authors.lastname: Milne
authors.forename: Marie
authors.initials: M
authors.lastname: Agrell-Kann
authors.forename: Bruce P
authors.initials: BP
authors.lastname: Ekholm
mesh_terms: D000179:Acrylates / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003872:Dermatitis / Q000628:therapy*; D005242:Fecal Incontinence / Q000451:nursing*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D063868:Patient Outcome Assessment; D011446:Prospective Studies; D014549:Urinary Incontinence / Q000451:nursing*
chemical_list: D000179:Acrylates